Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (25%) |
| §112 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FONTAINHAS, AURORA M | 1 | 38.0% | +49.1% |
| FETTEROLF, BRANDON J | 1 | 51.4% | +17.1% |
| LEE, CHIHYI NMN | 1 | 32.9% | +58.5% |
| MCCORMICK, CATHERINE LYNN | 1 | 48.8% | +35.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18222115 | NOVEL COMPOUNDS | LEE, CHIHYI NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039840 | Antibody Delivery | MCCORMICK, CATHERINE LYNN | 26d |
| 18395150 | Vaccine Therapy | FONTAINHAS, AURORA M | — |
| 18227103 | NOVEL COMPOUNDS | FETTEROLF, BRANDON J | — |
| 18222115 | NOVEL COMPOUNDS | LEE, CHIHYI NMN | — |
| Art Unit | Apps |
|---|---|
| 1649 | 1 |
| 1626 | 1 |
| 1628 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18395150 | Vaccine Therapy | FONTAINHAS, AURORA M | 1649 | DP | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18227103 | NOVEL COMPOUNDS | FETTEROLF, BRANDON J | 1626 | §112 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18222115 | NOVEL COMPOUNDS | LEE, CHIHYI NMN | 1628 | §102§103§112 | Final Rejection | — | Pending | Jul 14, 2023 |
| 18039840 | Antibody Delivery | MCCORMICK, CATHERINE LYNN | 1638 | §102 | Final Rejection | 26d | Pending | Jun 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial